K.S. Singh et al. / Journal of Organometallic Chemistry 691 (2006) 3509–3518
3511
2.2.5. Preparation of triazolato complexes [(g6-p-
cymene)Ru(LL){N3C2(CO2R)2}] (LL = acac, R = Me
(7), LL = bzac, R = Me (8); LL = (dbzm), R = Me (9),
LL = acac, R = Et (10); LL = (bzac), R = Et (11),
LL = dbzm, R = Et (12))
21.19 (s, Me, CHMe2), 30.75 (s, CH, CHMe2), 51.42 (d,
0
CH3, JC–H = 20.72 (CO2CH3)2), 80.63, 80.98 (s, CAA ),
85.21, 85.54 (s, C0BB), 95.87 (s, dbzm-cC), 98.80 (s, CPri),
127.34–130.93 (m, Ph), 139.30 (s, C(CO2Me)2), 153.83 (s,
CO2) 182.13, 182.78 (s, CO).
General procedure: A round bottom flask charged with
corresponding azido complex (4) (100 mg, 0.26 mmol) or
(5) (100 mg, 0.22 mmol) or (6) (100 mg, 0.20 mmol) was
added fivefold excess of dimethylacetylenedicarboxylate/
diethylacetylenedicarboxylate and CH2Cl2 (20 ml). The
mixture was stirred at room temperature and then the solu-
tion was reduced to ca. 3 ml on rotary evaporator. To this
solution was added 30 ml of hexane, whereby the com-
pound precipitated out as a yellow solid. The solid was col-
lected by centrifuged and washed with 2 · 20 ml of hexane
and dried under vacuum to gave the triazolato complexes
[(g6-p-cymene)Ru(LL){N3C2(CO2R)2}] (7–12).
Complex 10. LL = (acac), R = Et, 8 h, 77% (113 mg).
Anal. Calc. for C23H31N3O6Ru: C, 50.77; H, 5.88; N,
7.72%. Found: C, 50.25; H, 5.36; N, 7.87%. IR (KBr,
1
cmꢀ1): 1716 (mC@O), 1578, 1552, 1517 (mC@O + mC@C). H
NMR (CDCl3, d): 1.22 (t, 6H, JH–H = 4.8, CH2(CH3)2),
1.32 (t, 6H, JH–H = 4.0, CHMe2), 1.92 (s, 6H, acac-Me),
2.17 (s, 3H, Me (cym)), 2.78 (m, 1H, CHMe2), 4.30 (qt,
4H, JH–H = 7.12), 4.97 (s, 1H, acac-cH), 5.29 (dd, 2H,
JH–H = 10.52, JH–H = 6.04), 5.55 (dd, 2H, JH–H = 11.28,
JH–H = 6.12). 13C {1H} NMR (CDCl3, d): 14.21 (s, Me
(–CH2Me)), 17.68 (s, Me, CMe), 22.34 (s, Me, CHMe2),
26.67 (d, JC–H = 16.50, Me, acac-Me), 30.66 (s, CH,
0
Reaction time, yield, analytical and spectroscopic data
are as follows:
CHMe2), 60.55 (s, –CH2– (–CH2Me)), 80.11 (s, CAA ),
0
84.97 (d, CBB JC–H = 24.54), 98.98 (d, CH, acac-cC,
Complex 7. LL = (acac), R = Me, 12 h, 93% (128 mg).
Anal. Calc. for C21H27N3O6Ru: C, 48.59; H, 5.21; N,
8.10. Found: C, 48.25; H, 5.16; N, 7.87%. IR (KBr,
JC–H = 15.59), 99.72 (s, CMe), 101.28 (s, CPri), 140.26 (s,
C(CO2Et)2), 162.78 (s, (CO2)), 187.15 (s, CO).
Complex 11. LL = (bzac), R = Et, 10 h, 82% (114 mg).
Anal. Calc. for C28H33N3O6Ru: C, 55.12; H, 5.41; N, 6.89.
Found: C, 54.87; H, 5.23; N, 6.95%. IR (KBr, cmꢀ1): 1716
(mC@O), 1578, 1552, 1517 (mC@O + mC@C). 1H NMR (CDCl3,
d): 1.26 (m, 6H, Me), 1.28 (m, 6H, CHMe2), 2.07 (s, 3H
(bzac-Me)), 2.17 (s, 3H, Me (Cym)), 2.82 (m, 1H, CHMe2),
4.26, 4.29 (qt, 4H, JH–H = 3.2, –CH2– (CO2Et)), 5.62 (d,
2H, JH–H = 8.4), 5.65 (d, 2H, JH–H = 5.84), 5.58 (s, 1H,
cH-bzac), 7.31–7.35 (m, 3H), 7.71 (m, 2H). 13C {1H} NMR
(CDCl3, d): 14.15 (s, Me (CO2CH2Me)), 17.66 (Me-cymene),
22.21 (d, Me JC–H = 30.28, CHMe2), 27.61 (s, Me (bzac-
Me)), 30.68 (s, CH, CHMe2), 60.45, 61.19 (s, –CH2–
1
cmꢀ1): 1723 (mC@O), 1579, 1560, 1517 (mC@O + mC@C). H
NMR (CDCl3, d): 1.21 (d, 6H, JH–H = 6.92, CH(CH3)2),
1.91 (s, 6H, acac-Me), 1.94 (s, 3H), 2.75 (m, 1H,
CH(CH3)2), 3.86 (s, 6H, (OCH3)), 4.95 (s, 1H, acac-cH),
5.29 (m, 2H), 5.60 (m, 2H). 13C {1H} NMR (CDCl3, d):
17.65 (s, Me, CMe), 22.32 (s, Me, CH(Me)2), 26.60 (s,
acac-Me), 30.68 (s, CH, CHMe2), 51.66 (s, CH3,
0
0
CO2(CH3)), 80.07 (s, CAA ), 84.99 (s, CBB ), 98.93 (s, CH,
acac-c C), 99.75 (s, C, CMe), 101.30 (s, CPri), 140.22 (s,
C(CO2Me)2), 162.90 (s, (CO2)), 187.12 (s, acac-CO).
Complex 8. LL = (bzac), R = Me, 18 h, 84% (112 mg).
Anal. Calc. for C26H29N3O6Ru: C, 53.65; H, 4.98; N, 7.22.
Found: C, 53.18; H, 4.73; N, 6.95%. IR (KBr, cmꢀ1): 1716
(mC@O), 1578, 1552, 1517 (mC@O + mC@C). 1H NMR (CDCl3,
d): 1.24 (d, 6H, JH–H = 4, CH(CH3)2), 1.98 (s, 3H, bzac-Me),
2.06 (s, 3H, cym), 2.79 (m, 1H, CH(CH3)2), 3.49 (s, 6H,
0
0
,
(CO2Et)), 80.30 (t, CAA , JC–H = 16.50), 85.02 (d, CBB
JC–H = 40.34), 96.17 (s, CH, bzac-cC), 99.71 (s, CMe),
101.20 (s, CPri), 127.10–130.84 (m, Ph), 138.90, 140.05 (s,
C(CO2Et)), 162.80 (s, CO2), 180.87 (s, CO), 189.12 (s, CO).
Complex 12. LL = (dbzm), R = Et: 12 h, 81% (109 mg).
Anal. Calc. for C33H35N3O6Ru: C, 59.09; H, 5.22; N,
6.26. Found: C, 58.75; H, 4.98; N, 6.12%. IR (KBr,
0
(OCH3)), 5.33 (m, 2H, HAA ), 5.48 (s, 1H, bzac-H), 5.62
0
(m, 2H, HBB ), 7.30 (m, 3H, bzac-Ph), 7.68 (m, 2H, bzac-
1
Ph). 13C {1H} NMR (CDCl3, d): 17.67 (s, Me, CMe),
22.21 (d, Me, JH–H = 31.80, CHMe2), 27.58 (s, Me, bzac-
Me), 30.73 (s, CH, CHMe2), 51.62 (s, Me, CO2Me), 80.30
cmꢀ1): 1723 (mC@O), 1579, 1560, 1517 (mC@O + mC@C). H
NMR (CDCl3, d): 1.26 (m, 6H, Me, CO2Et), 1.29 (m, 6H,
CHMe2), 2.17 (s, 3H, Me (Cym.)), 2.82 (m, 1H, CHMe2),
4.26 (qt, 4H, JH–H = 3.2, –CH2– (CO2Et)), 5.46 (d, 1H,
JH–H = 6), 5.67 (d, 1H, JH–H = 6), 5.72 (d, 2H, JH–H = 6),
6.18 (s, 1H, dbzm-cH), 7.35 (m, 6H), 7.77 (m, 4H). 13C
{1H} NMR (CDCl3, d): 14.10 (s, Me (CO2Et)2), 17.72 (s,
Me (cym)), 22.21 (d, JC–H = 30.28, Me (CHMe2)), 30.68
(s, CH, (CHMe2)), 61.19 (s, –CH2– (CO2Et)), 80.87 (d,
CAA , JC–H = 29.88), 85.13 (d, CBB JC–H = 30.99), 94.85
(s, CH (dbzm-cC)), 99.54 (s, CMe), 101.19 (s, CPri),
127.34–130.98 (m, Ph), 139.91 (s, C(CO2Et)), 162.81 (s,
(CO2)), 181.94, 182.58 (s, CO).
0
0
(d, CAA , JC–H = 19.60), 85.45 (d, CBB , JC–H = 19.60),
96.79 (s, CH, bzac-cC), 99.79 (s, CMe), 101.30 (s, CPri),
127.12–130.81 (m, Ph), 140.05 (s, C(CO2Me)), 162.99 (s,
CO2), 180.94 (s, CO), 189.13 (s, CO).
Complex 9. LL = (dbzm), R = Me, 18 h, 87% (111 mg).
Anal. Calc. for C31H31N3O6Ru: C, 57.93; H, 4.82; N,
6.53. Found: C, 57.48; H, 4.66; N, 6.28%. IR (KBr,
0
0
1
cmꢀ1): 1723 (mC@O), 1579, 1560, 1517 (mC@O + mC@C). H
NMR (CDCl3, d): 1.29 (d, 6H, JH–H = 6.92, CHMe2),
2.17 (s, 3H, Me - cymene), 2.87 (m, 1H, CHMe2), 3.77 (s,
6H, (CO2Me)2), 5.42 (d, 1H, JH–H = 6), 5.46 (d, 1H,
JH–H = 6), 5.67 (d, 1H, JH–H = 6), 5.72 (d, 1H, JH–H = 6),
6.16 (s, 1H, dbzm-cH), 7.35 (m, 6H, Ph), 7.77 (m, 4H,
Ph). 13C {1H} NMR (CDCl3, d): 17.79 (s, CH3, CMe),
2.2.6. [(g6-p-cymene)Ru(acac){N3C2HCN}] (13)
Caution: These reactions should perform under well ven-
tilation hoods.